OrphanDrug
OrphanDrug
Pharma Knowledge Base

tibial muscular dystrophy

MeSH: C536815ORPHA: 609

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

late-onset muscular dystrophy beginning in the anterior comparment of the legs

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with tibial muscular dystrophy, sourced from HPO and Orphanet clinical annotations.

MyopathySteppage gaitEMG: myopathic abnormalitiesIncreased variability in muscle fiber diameterCentrally nucleated skeletal muscle fibersRimmed vacuolesMildly elevated creatine kinaseFoot dorsiflexor weaknessPeroneal muscle atrophyIncreased muscle lipid contentAnkle weaknessClumsinessQuadriceps muscle weaknessProximal lower limb muscle weaknessDistal upper limb muscle weaknessGait disturbance

Classification & Codes

MeSH Code

C536815

Orphanet Code

ORPHA:609
tibial muscular dystrophy
MeSHC536815
OrphanetORPHA:609
Treatments0 drug(s)
Symptoms on record16 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO